[go: up one dir, main page]

WO2025075501A1 - Dispositif de stimulation ultrasonore transcrânienne - Google Patents

Dispositif de stimulation ultrasonore transcrânienne Download PDF

Info

Publication number
WO2025075501A1
WO2025075501A1 PCT/NL2024/050538 NL2024050538W WO2025075501A1 WO 2025075501 A1 WO2025075501 A1 WO 2025075501A1 NL 2024050538 W NL2024050538 W NL 2024050538W WO 2025075501 A1 WO2025075501 A1 WO 2025075501A1
Authority
WO
WIPO (PCT)
Prior art keywords
receptacle
tus
ultrasound
elastic
ultrasonic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/NL2024/050538
Other languages
English (en)
Inventor
Bob Peter BRAMSON
Sjoerd William MEIJER
Sibrecht BOUWSTRA
Lennart VERHAGEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Radboud Universiteit Nijmegen
Original Assignee
Radboud Universiteit Nijmegen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radboud Universiteit Nijmegen filed Critical Radboud Universiteit Nijmegen
Publication of WO2025075501A1 publication Critical patent/WO2025075501A1/fr
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/225—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
    • A61B17/2251—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves characterised by coupling elements between the apparatus, e.g. shock wave apparatus or locating means, and the patient, e.g. details of bags, pressure control of bag on patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B17/22—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for
    • A61B17/225—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves
    • A61B17/2251—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves characterised by coupling elements between the apparatus, e.g. shock wave apparatus or locating means, and the patient, e.g. details of bags, pressure control of bag on patient
    • A61B2017/2253—Implements for squeezing-off ulcers or the like on inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; for invasive removal or destruction of calculus using mechanical vibrations; for removing obstructions in blood vessels, not otherwise provided for for extracorporeal shock wave lithotripsy [ESWL], e.g. by using ultrasonic waves characterised by coupling elements between the apparatus, e.g. shock wave apparatus or locating means, and the patient, e.g. details of bags, pressure control of bag on patient using a coupling gel or liquid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0021—Neural system treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N7/00—Ultrasound therapy
    • A61N2007/0004—Applications of ultrasound therapy
    • A61N2007/0021—Neural system treatment
    • A61N2007/0026—Stimulation of nerve tissue

Definitions

  • the present invention is in the field of an apparatus for generating mechanical vibrations of ultrasound frequency, in particular an improved wearable ultrasound device, configured for ultrasound therapy, in particular for transcranial stimulation, a kit of parts comprising said device, and a corresponding method, using said device in therapy.
  • Ultrasound is an oscillating sound pressure wave with a frequency greater than the upper limit of the human hearing range (hence ultra-sound).
  • Ultrasound devices may operate with frequencies from 20 kHz up to several gigahertz. Ultrasound may be used in many different fields. Ultrasonic devices are used to detect objects and measure distances. Ultrasonic imaging (sonography) is used in both veterinary medicine and human medicine. In the non-destructive testing of products and structures, ultrasound is used to detect invisible flaws. Ultrasonic imaging typically uses frequencies of 2 megahertz and higher. The power density is generally limited, e.g. less than 1 watt/cm 2 to avoid heating and cavitation effects in the object under examination.
  • Ultrasonic imaging applications include industrial non-destructive testing, quality control and medical uses.
  • Industrially, ultrasound is used for cleaning and for mixing, and to accelerate chemical processes. At higher power levels, ultrasound may be useful for medical treatment or for changing the chemical properties of substances.
  • a standard transducer array with beamformer which consists of multiple, e.g. 64 to 128, trans- mit/receive channels, is straightforward to implement if design constraints such as size and power are relaxed.
  • Ultrasound can be used in therapy. It relates to use of ultrasound to transmit acoustic energy into the body, potentially for therapeutic benefit.
  • dedicated hand-held devices are used. These dedicated devices suffer from various drawbacks, amongst others a need of a wire between transducer and monitor, handheld use of the device; hence they are not suited for long-term monitoring.
  • Some prior art devices may require a trained professional to handle the transducer and to evaluate what is seen or what is to be achieved in terms of therapy.
  • ultrasound may be considered, including modulation of blood flow, reduction of swelling and oedema, and gentle massage of cells, in muscle tendons and/ or ligaments, and the modulation of cell activity and plasticity in the peripheral and central nervous systems
  • thermal and mechanical effects are due to the absorption of the sound waves.
  • Mechanical effects are from particle displacement, radiation force, cavitation, and streaming.
  • ultrasound therapy relate to physiotherapy, lithotripsy, High Intensity Focused Ultrasound (HIFU), targeted ultrasound drug delivery, trans-dermal ultrasound drug delivery, ultrasound haemostasis, cancer therapy, transcranial application, and ultrasound assisted thrombolysis. It may use focused ultrasound (FUS) or unfocused ultrasound.
  • HIFU High Intensity Focused Ultrasound
  • FUS focused ultrasound
  • unfocused ultrasound unfocused ultrasound.
  • HIFU In the above applications, the ultrasound passes through human tissue where it is the main source of the observed biological effect.
  • HIFU generally uses lower frequencies than medical diagnostic ultrasound (250-2000 kHz), but significantly higher time-averaged intensities.
  • the treatment is often guided by Magnetic Resonance Imaging (MRI); the combination is then referred to as Magnetic resonance-guided focused ultrasound (MRgFUS).
  • Transcranial ultrasound may be for used in aiding tissue plasminogen activator treatment, for instance in stroke patients, in a procedure called ultra- sound-enhanced systemic thrombolysis.
  • the transcranial technology is currently being used in ongoing research. Typical issues therein relate to a lack of stability and usability.
  • Transcranial ultrasonic stimulation is a relatively novel technique that can be used to influence brain activity non-invasively. It employs ultrasonic waves that travel through the skin and skull and interact with ongoing neural activity. This technique has benefits over existing methods of neuromodulation that are currently in wide use. Namely, TUS can be targeted at deeper brain circuits as compared to electrical or magnetic brain-stimulation techniques. Additionally, stimulation can be applied more precisely. This means TUS has potential in treatment of multiple neurological or neuro-psychological disorders that are caused by aberrations of deep neural activity. Further, it can be (and is currently) used in cognitive neuroscience experiments to probe the causal influences of deep-brain circuits that, prior to the introduction of TUS, could not be reached without opening the skull.
  • TUS needs to be applied using a transducer (a stimulator emitting focused sound waves) that is coupled to the scalp of a human being with no air in between the transducer and scalp. This is important because air will block sound waves at least to some extent.
  • ultrasound gel and gel-pads are used to ultrasonically couple a device to the skull, but this is challenging, as gel-only coupling only allows direct placement of the transducer flat on the scalp, gel-pads do not allow flexible placement of the transducer and can slide, and ultrasonic coupling is easily lost, leading to failed stimulation. This practical problem makes application of TUS difficult in both research and clinical settings.
  • CN 111 888 671 A recites an ultrasonic transducer coupling device for transcranial ultrasonic stimulation of a human body.
  • the ultrasonic transducer coupling device comprises an automatic pitch adjusting mechanism, an ultrasonic transducer and a water bag structure, wherein the automatic pitch adjusting mechanism is connected with distal and proximal ends of the ultrasonic transducer and is used for adjusting an axial distance between the ultrasonic transducer and scalp of a tester; the ultrasonic transducer is used for generating focused ultrasonic waves required for the transcranial ultrasonic stimulation; the water bag structure is used for storing a liquid couplant and comprises a liquid couplant internal cavity and a liquid couplant external cavity, and a sound-transmitting film in contact with the human body is arranged at the distal end of the liquid couplant internal cavity of the water bag structure; and the liquid couplant internal cavity communicates with the liquid couplant external cavity, and the liquid couplant internal cavity and the liquid couplant external cavity store a liquid couplant which is used for conducting ultrasonic waves to the scalp of the tester.
  • the automatic pitch adjusting mechanism is connected with distal and proximal ends of the
  • the ultrasonic transducer coupling device has the advantages that the depth of stimulation can be adjusted, the use method is simple, accurate positioning can be achieved, the safety is good, and the like.
  • US 2011/028867 Al recites an apparatus for non-invasive delivery of focused ultrasound to a targeted area of a biological tissue, and a method thereof.
  • the apparatus comprises an ultrasound wave generator to provide an amplified modulated waveform, a resonance circuit for tuning the waveform to have a predetermined frequency, an ultrasound transducer for generating a focused beam of the tuned waveform, an applicator supporting the ultrasound transducer, and an ultrasound-tissue coupling bag detachably mounted to the ultrasound transducer.
  • US 2008/033297 Al recites a system for the diagnostic or therapeutic treatment of a patient's neural tissues.
  • the system includes at least a means to directly or indirectly acoustically expose or acoustically displace at least a first tissue portion.
  • the system further includes a means to impose, directly or indirectly, an electromagnetic, electrical, magnetic or optical field on at least a second neural tissue portion.
  • the combined or cooperative action of the acoustic exposure/displacement and the field, whether sequentially or simultaneously applied, causes at least one diagnostically or therapeutically useful mechanism.
  • the two tissue portions may be the same portion or different portions
  • the present invention relates in a first aspect to a transcranial ultrasonic stimulation (TUS) device, in particular a wearable device (100) for stimulating brain activity, that is for modulating brain activity, or even altering neural processing, by providing ultrasound to the brain or neurons.
  • TUS transcranial ultrasonic stimulation
  • Inventors have provided a typically balloon shaped coupler, that can be attached to the TUS transducers, such as by using a 3d printed holder.
  • This balloon may be filled with water, which allows the ultrasound to pass through the balloon unimpeded, and undistorted, whilst ultrasonic coupling is easier.
  • the balloon can be created in multiple sizes to fit to a corresponding transducer.
  • the transducer can be made thicker, and shallower, by adding or releasing liquid (water), such as depending on the needs of the researcher/clinician.
  • its shape allows for adjustments of the angle in which the transducer is placed in relation to the skull. It is attached to the transducer, which assures it stays in place. Its property of being fixed, yet flexible is what makes it so successful. It is considered important, for the efficacy of the present TUS, that some materials can absorb the sound waves, at least to some extent, thereby reducing the effective amplitude of modulation applied. In the present coupler this is not the case, as been extensively tested. Thereto an elastic material is used. Ultrasound is allowed to pass through unimpeded.
  • the ultrasonic wave coupler comprises at least one elastic receptacle (21), the receptacle comprising a fluid (22), in particular a liquid, that is, enclosing the fluid between the ultrasound transmitter 10 and the receptacle, such as wherein the elastic receptacle effectively only has one layer of elastic material, or elastic layers attached to one and another, further comprising an opening (23) configured to let ultrasound wave through, and a restrictor (24) configured for attaching the ultrasonic wave coupler into the ultrasound transmitter.
  • elasticity is the ability of a body to resist a distorting influence and to return to its original size and shape when that influence or force is removed.
  • Solid objects will deform when adequate loads are applied to them; if the material is elastic, the object will return to its initial shape and size after removal. This is in contrast to plasticity, in which the object fails to do so and instead remains in its deformed state.
  • elastomers being polymers with viscoelasticity, i.e. both viscosity and elasticity.
  • the present invention relates to a method for use of the present device in therapy or the like, such as in Transcranial ultrasonic stimulation (TUS); neuro-modulation; coupling solutions; psychiatry; neurology, and cognitive neuroscience.
  • TUS is a novel brain stimulation technique that has the potential to revolutionize cognitive neuroscience, neurology, and psychiatry. Improving its usability is important for the facilitation of widespread use.
  • the present invention therefore relates to a transcranial ultrasonic modulation (TUS) device, in particular a wearable device 100 for non-invasive modulation of brain activity, in particular of brain cells, comprising an ultrasound transmitter 10 comprising at least one transducer 110 for providing ultrasonic waves, and a transmitter body 11 for incorporating the at least one transducer, an ultrasonic wave coupler 20 for transmitting sound waves in ultrasonic wave contact with the a least one transducer and configured to provide ultrasonic wave contact to a human scalp, wherein the ultrasonic wave coupler comprises at least one elastic receptacle 21, the receptacle comprising a fluid 22, in particular a liquid, an opening 23 configured to let ultrasound wave through, and a restrictor 24 configured for attaching the coupler to the ultrasound transmitter, that is, for keeping the receptacle in place relative to the coupler.
  • the ultrasonic wave coupler is configured as is detailed to couple ultrasound.
  • the present invention relates to a kit of parts comprising the ultrasonic wave coupler 20 according to the invention and optionally the ultrasound transmitter 10.
  • the present invention relates to a method of Transcranial ultrasonic stimulation (TUS), comprising the steps of providing the present device, bringing the device to a person’s head, and providing ultrasonic waves to the head.
  • TUS Transcranial ultrasonic stimulation
  • the present invention relates in a first aspect to a device according to the invention.
  • the elastic material is selected from elastomers, from polymers, from copolymers, such as from natural rubbers, from synthetic rubbers, in particular from poly siloxanes, such as polydimethylsiloxanes (PDMS), such as natural and synthetic polymers, in particular natural and synthetic rubbers, such as diene-comprising polymers, in particular polyisoprene, polybutadiene, fluoro-elastomers, and polychloroprene, non-diene-comprising polymers, in particular butyl rubber polyisobutylene, polysiloxanes, polyurethane, thermoplastic polymers, in particular SIS and SBS block copolymers, and urethanes.
  • PDMS polydimethylsiloxanes
  • the elastic material has a bulk modulus of 0.5 -10 GPa, such as 1-5 GPa (ISO 9110-1 : 1990 EN).
  • elasticity is considered the ability of a body to resist a distorting influence and to return to its original size and shape when that influence or force is removed. Solid objects may deform when adequate loads are applied to them; if the material is elastic, the object will return to its initial shape and size after removal.
  • these materials of the wall have an elastic modulus of 0.5 MPa- 2GPa, such as 10-100 MPa.
  • suitable materials with higher moduli could be used, such as up to lOOOGPa (ASTM El 11).
  • the elastic material has a density p of 0.8-3 kg/dm 3 in particular according to ISO 12154:2014(en), preferably a material with a Poisson’s ratio of 0.48-0.50 in particular according to ASTM D638, ISO 527, in particular about or exactly 0.50.
  • the elastic material has a shore A hardness (ASTM D 2240; ISO 7619-1) of 10-100, in particular 15-25, and/or self-bleeding, and/or a shrinkage of ⁇ 1%, in particular ⁇ 0.2%.
  • the elastic material has a self-bleeding.
  • the elastic material has a shrinkage of ⁇ 1%, in particular ⁇ 0.2%, in particular ⁇ 0.1%.
  • the elastic material has a tensile strength of 1-10 N/mm 2 , in particular 3-8 N/mm 2 , more in particular 5-7 N/mm 2 .
  • the elastic material has a viscosity of 1-10 Pa s, in particular 2-8 Pa s, more in particular 4-6 Pa s.
  • the elastic material has a tensile strength (EN ISO 1421) of 1-10 N/mm 2 , in particular 3.5-8 N/mm 2 , more in particular 6-7.5 N/mm 2 .
  • the elastic material has a strength at break (EN ISO XYZ) of 5-25 N/mm, in particular 10-20 N/mm, more in particular 12-18 N/mm.
  • the elastic material comprises 0.1-10 wt.% plasticizer, in particular 0.5-4 wt.%, such as 1-3 wt.%, such as silicone oil.
  • the above specifics of the elastic material are found to contribute to the performance of the present ultra sonic wave coupler, and more in particular the receptacle thereof. Reflectance by the present receptacle/coupler of ultra sonic waves, transmitted by the present transmitter, is minimized, a field of view of the ultrasonic waves is not much impaired, contact with a skin of a skull is optimized, focusing remains good, etc.
  • the receptacle (21) is a hollow elastic body having a wall, and is selected from the elastic body having an outer diameter Oa, and from a conus shaped elastic body, the conus shaped elastic body having a tip or a flattened tip and in particular having a cross-section selected from circular, ellipsoid, triangular, rectangular, hexagonal, octagonal, and multigonal, the elastic body having a height H, the elastic body having a volume V, wherein the wall has a thickness ti of 0.001-5 mm, and/or wherein the elastic body has a cross-sectional shape selected from ellipsoidal and circular, and/or wherein a side of the receptacle has a surface area of 20-50 mm 2 , preferably 30-40 mm 2 , such as 35 mm 2 .
  • the elastic body of the receptacle is a one piece body, such as obtained by 3D-printing, or by moulding.
  • an acoustic reflectance of the receptacle is ⁇ 10%, in particular ⁇ 1%, more in particular ⁇ 10' 2 %, relative to an input signal.
  • the receptacle comprises at least one outlet for releasing fluid, in particular for releasing gas.
  • At least one of the at least one inlet and at least one outlet is provided with a valve, in particular a one way valve providing one of liquid inlet and liquid outlet only, respectively.
  • the at least one transducer provides focused ultrasonic waves.
  • the receptacle comprises at least one inlet for releasing fluid from the receptacle, or for filling the receptacle with fluid.
  • the receiver part is configured to receive the receptacle.
  • the ultrasonic wave coupler has a width of 1-20 cm, a height of 1-10 cm, and a length of 1-20 cm, in particular wherein the ultrasonic wave coupler is balloon shaped.
  • the device is configured to provide ultrasonic waves.
  • the device is a handheld device, a mechanically held device, or a wearable device.
  • the coupler comprises a coupler fixator (25) for fixing the coupler to the ultrasonic transmitter.
  • the restrictor comprises two sub-parts 24a, b, wherein the two sub-parts are configured to partially incorporate the receptacle, and wherein the two sub-parts are removably attached to one and another. Hence the receptacle is also removably attached.
  • the restrictor is provided as a connector for permanently fixing a top part of the receptacle to a bottom part of the receptacle, such as a ring, in particular an elastic ring, more in particular an elastic ring of the same material as the receptacle, even more in particular wherein the connector is configured for connecting the receptacle to the ultrasound transmitter.
  • the liquid is a de-gassed liquid, such as de-gassed water, or oil.
  • the ultrasound transmitter (10) is configured to provide pulses with a frequency of 5-700 kHz, an amplitude of 10 pW/cm 2 -100000 mW/cm 2 , in particular 10-30 mW/cm 2 ’ -during a period of time of 0.1-3600 sec, in particular 30- 1200 sec, and with a total (integrated) power of 1-1000 W/cm 2 .
  • the ultrasound transmitter (10) is configured to provide alternating pulses with an intermittent idle period, wherein a time of each pulse individually is from 10 pse-1000 msec, in particular 0.5-500 msec, more in particular 1- 100 msec, and wherein a time of each intermittent idle period individually is from 70 psec - 10000 msec, in particular 2-1000 msec, more in particular 50-200 msec, and/or to provide alternating pulses with a pulse/idle frequency of 0.1-1000 Hz, in particular a pulse/idle frequency of 1-300 Hz, more in particular a pulse/idle frequency of 2-100 Hz.
  • the present device comprises a head fixator for fixing the device to a person's head, such as an adhesive material (107), a strap, a headset, a belt, and an elastic band, and an adhesive material, wherein the fixing means is preferably size adjustable.
  • a head fixator for fixing the device to a person's head, such as an adhesive material (107), a strap, a headset, a belt, and an elastic band, and an adhesive material, wherein the fixing means is preferably size adjustable.
  • the present device further comprises at least one of an amplifier, a controller, a storage unit, a connector, a power supply , a memory, a transceiver, an on-off switch, a status indicator 4, ventilation openings, at least one sensor in transceiving connection with the controller, in particular wherein the at least one sensor is selected from a temperature sensor, and a pressure sensor, wherein the temperature sensor is configured to measure a temperature in the liquid of the receptacle, and wherein the pressure sensor is configured to measure pressure in the liquid of the receptacle, and software stored on the memory.
  • the at least one controller may be used for read-out, for control of sensors, for control of the device, for control of TUS measurement, for providing a TUS measurement protocol, etc.
  • At least one of the electrical pulse generator, the processor, the controller, the sensor, an amplifier, a controller, a storage unit, a connector, a power supply, a memory, a transceiver, an on-off switch, a status indicator, ventilation openings, and software stored on the memory, are provided in a central part of the device for placement on a head of the person, such as to a side of the forehead, preferably in one housing.
  • the present method TUS is applied for a predetermined duration of time of 1 sec - 2 hours.
  • the present method TUS is applied with a predetermined constant amplitude of 0.001 pW/cm 2 - 10000 mW/cm 2 , in particular 1-10 mW/cm 2 .
  • the present method TUS is applied with a varying amplitude of between 1-10000 pW/cm 2 .
  • the present method TUS is applied with intermittent bursts of a predetermined time of 2 msec-1 sec and with a predetermined interval of 2 msec- 1 sec.
  • a total number of TUS periods is limited to a predetermined number, in particular 10-10 3 .
  • the present method through wireless contact settings are adapted, such as a frequency, impedance, amplitude, duration of time, moment of application of TUS, delay, constant amplitude, varying amplitude, temperature of the liquid in the receptacle, pressure of the liquid in the receptacle, duration of bursts, and number of TUS periods, and/or wherein statistical data is gathered.
  • an amount of fluid in the receptacle is changed, selected from release of gas, release of fluid, and addition of fluid.
  • Figures la-b show a prior art device, fig. 2a the present coupler, fig. 2b the present device, fig. 3 a the present receptacle, and fig. 3b schematics of the present coupler.
  • Figures la shows a prior art device, in particular a handheld device, attached to a power cable, and ultrasound waves
  • fig. lb shows a slightly enlarged portion of fig. la
  • Fig. 2a shows the present coupler 20, having a height H, the elastic receptacle 21, filled with fluid 22, and two-part restrictor (top and bottom) 24a, b.
  • Fig. 2b shows the present device 100, including the present coupler 20 attached to the ultrasound transmitter 10, in particular to transmitter body 11.
  • Fig. 3a shows the present receptacle with holes for allowing screws to be used to attach top part of the restrictor 24a to a bottom part 24b thereof.
  • Fig. 3b shows schematics of the present coupler 20, with an outer dimension Od, a receiver part 26 for the coupler, and a central opening 23.
  • silicone oil such as Silicone oil 5 cSt, may be added, typically in small quantities (0.1-10 wt.%).
  • Avoidance behaviour is considered to be a key predictive factors in maintaining pervasive emotional disorders, such as anxiety.
  • Previous studies have shown that the Amygdala are important regions involved in threat-assessment, and consequent avoidance, when people make approach or avoid decisions, based on predicted reward or punishment.
  • Disruption or ablation of the amygdala in animal models results in reduced avoidance and increased approach behaviour, allowing animals to gain rewards even in the presence of threat.
  • Being able to disrupt amygdala activity might provide a way to reduce avoidance biases in patients with anxiety-related disorders, allowing them to benefit from exposure treatment.
  • TUS Transcranial, typically focused, Ultrasound Stimulation
  • the inventors performed a study which is aimed at manipulating approach/avoi dance behaviour, through modulation of amygdala and ventral striatum by TUS, whilst participants make approach/avoi d decisions based on threat (electrical shocks) and reward information (monetary bonusses).
  • Transcranial Ultrasonic Stimulation is a non-invasive neuromodulation technique that can achieve focal modulation of deep brain structures.
  • the outcomes of this study provide a first stepping-stone for the development of TUS based interventions aimed at reducing anxiety disorders.
  • the primary objective is to influence amygdala and ventral striatal neuronal activity, thereby changing their influence on consequent approach/avoi dance decisions.
  • Inventors are able to (1) discern the neuromodulatory effects of amygdala-TUS on standard physiological indices of decision making under threat, such as increases in pupil size as recorded with an eye-tracker and heart rate, recorded using ECG electrodes (2) to use computational modelling of choice data to determine the influence of TUS on subjective value of threat and reward offers, thereby clarifying each regions’ role in balancing threat and reward information.
  • Heart rate (HR) is used index responses to different reward and shock levels on offer, and the potential change in HR during modulation. HR is measured using electrocardiography (ECG), using lead electrodes attached to the skin surface.
  • Pupil diameter (PD) is used to index differential pupil dilation responses to the stimuli in separate modulation conditions. PD is recorded by video-based eye-tracking.
  • Transcranial Ultrasonic Stimulation is delivered using a NeuroFUS ProTM system (Sonic Concepts Inc. Bothell, Washington, USA) using two piezoelectric ultrasound transducers.
  • the transducers have a centre frequency of 500 or 250 kHz.
  • the choice of 250 vs 500 kHz transducer is based on simulation of effects; depending on the ability to focus specifically enough on the (relatively small) ventral striatum inventors select the more focal 500 kHz, or the less focal 250 kHz transducer.
  • TUS is delivered using a solid water coupling system between the transducer and the scalp. Each transducer is appropriate for neuromodulatory use in the context of the experiment.
  • TUS parameters (5-1000 Hz pulse repetition frequency, 10- 50% duty cycle, that is a ratio between active/inactive) that are proven to be safe in humans.
  • the exact parameters of the TUS protocol is determined based on testing on the pilot-participant group, for finding protocols that can be masked using an auditory mask.
  • the TUS pulses are delivered interleaved over the left and right amygdala, or ventral striatum, to avoid ultrasonic wave interference from the two modulation sites.
  • Trial-level ultrasonic stimulus duration is 3 seconds. Cumulative ultrasonic stimulus duration for the each modulation session in the experiment is 300 seconds.
  • Verum TUS will be delivered at an intracranial spatial-peak pulse-averaged intensity (Isppa) below 20 W/cm 2 , in line with international guidelines and the Donders SOP.
  • Isppa intracranial spatial-peak pulse-averaged intensity
  • the duty cycle is lower for protocols with a lower pulse-repetition frequency and for protocols with a higher intensity. All safety parameters fall within the guidelines specified in the Donders NIBS standard operating procedures (i.e. mechanical index ⁇ 1.0, Isppa intracranial ⁇ 20 W/cm 2 , thermal rise in the brain ⁇ 1 °C, acoustic peak pressure below 2 MPa).
  • the present coupler (balloon) is placed on the transducer.
  • Ultrasound gel in between the coupler and the transducer is preferred for proper coupling.
  • MRI head scan is prepared, in order to better direct the ultrasound waves into the head to a required location.
  • the MRI scan is always collected in an earlier session. Before the start of the experiment the target region is highlighted in the MRI scan, to ensure easy targeting.
  • Inventors locate the participant's head in the room using infrared trackers. This involves placing a tracker on the participant's head, after which the head shape is recorded and overlayed with the head shape obtained from the MRI. This ensures that ultrasound localisation software is capable of identifying a location of the participants brain is in the room.
  • Neuronavigation the participant’s anatomical scan is loaded into a neuronavigation system (Localite) and registered to their actual head. The TUS device will also be registered in the neuronavigation system. This standard procedure allows accurate targeting of TUS to the appropriate targets throughout the experiment.
  • the next step is to see approximately where the ultrasound modulators are best placed (not exactly known yet at this stage). This is done by sliding the transducer over the head until inventors observe that the ultrasound beam overlaps with the highlighted target area. Then, inventors can draw a circle for quick placement.
  • the hair or skull is prepared, i.e. ultrasound gel is smeared between the hairs so that there are no air bubbles between hair and skull.
  • the participant and the transducer coupling are then continuously monitored. If the gel pad slips, the coupling, including aiming, preparing, and smearing gel in the hair, starts again.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgical Instruments (AREA)
  • Percussion Or Vibration Massage (AREA)

Abstract

La présente invention concerne le domaine d'un appareil pour générer des vibrations mécaniques de fréquence ultrasonore, en particulier un dispositif à ultrasons portable amélioré, conçu pour une thérapie ultrasonore, en particulier pour une stimulation transcrânienne, un kit de pièces comprenant ledit dispositif, et un procédé correspondant, utilisant ledit dispositif en thérapie.
PCT/NL2024/050538 2023-10-03 2024-10-03 Dispositif de stimulation ultrasonore transcrânienne Pending WO2025075501A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL2035948 2023-10-03
NL2035948A NL2035948B1 (en) 2023-10-03 2023-10-03 Transcranial ultrasound stimulation device

Publications (1)

Publication Number Publication Date
WO2025075501A1 true WO2025075501A1 (fr) 2025-04-10

Family

ID=89164377

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2024/050538 Pending WO2025075501A1 (fr) 2023-10-03 2024-10-03 Dispositif de stimulation ultrasonore transcrânienne

Country Status (2)

Country Link
NL (1) NL2035948B1 (fr)
WO (1) WO2025075501A1 (fr)

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5113848A (en) * 1989-10-02 1992-05-19 Richard Wolf Gmbh Apparatus for shock wave therapy
US20080033297A1 (en) 2006-08-02 2008-02-07 Sliwa John W Neural tissue stimulation, assessment, mapping, and therapy utilizing targeted acoustic mechanisms
US20110028867A1 (en) 2009-07-29 2011-02-03 Seh-Eun Choo Apparatus and method for non-invasive delivery and tracking of focused ultrasound generated from transducer
WO2014013285A1 (fr) * 2012-07-16 2014-01-23 Super Sonic Imagine Appareil et procédé de détermination de positions optimales d'une sonde hifu
US20150135840A1 (en) * 2012-08-29 2015-05-21 Thync, Inc. Systems and devices for coupling ultrasound energy to a body
US9061133B2 (en) * 2012-12-27 2015-06-23 Brainsonix Corporation Focused ultrasonic transducer navigation system
US20170001043A1 (en) * 2013-12-23 2017-01-05 Theraclion Sa Device for treatment of a tissue and method of preparation of an image of an image-guided device for treatment of a tissue
CN107362465A (zh) * 2017-07-06 2017-11-21 上海交通大学 一种用于人体经颅超声刺激与脑电记录同步的系统
US20190060675A1 (en) * 2015-10-16 2019-02-28 Madorra Inc. Ultrasound device for vulvovaginal rejuvenation
KR20200049241A (ko) * 2018-10-31 2020-05-08 (주)클래시스 뇌질환 치료를 위한 초음파 장치
CN111888671A (zh) 2020-08-06 2020-11-06 上海交通大学 一种用于人体经颅超声刺激的超声换能器耦合装置

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5113848A (en) * 1989-10-02 1992-05-19 Richard Wolf Gmbh Apparatus for shock wave therapy
US20080033297A1 (en) 2006-08-02 2008-02-07 Sliwa John W Neural tissue stimulation, assessment, mapping, and therapy utilizing targeted acoustic mechanisms
US20110028867A1 (en) 2009-07-29 2011-02-03 Seh-Eun Choo Apparatus and method for non-invasive delivery and tracking of focused ultrasound generated from transducer
WO2014013285A1 (fr) * 2012-07-16 2014-01-23 Super Sonic Imagine Appareil et procédé de détermination de positions optimales d'une sonde hifu
US20150135840A1 (en) * 2012-08-29 2015-05-21 Thync, Inc. Systems and devices for coupling ultrasound energy to a body
US9061133B2 (en) * 2012-12-27 2015-06-23 Brainsonix Corporation Focused ultrasonic transducer navigation system
US20170001043A1 (en) * 2013-12-23 2017-01-05 Theraclion Sa Device for treatment of a tissue and method of preparation of an image of an image-guided device for treatment of a tissue
US20190060675A1 (en) * 2015-10-16 2019-02-28 Madorra Inc. Ultrasound device for vulvovaginal rejuvenation
CN107362465A (zh) * 2017-07-06 2017-11-21 上海交通大学 一种用于人体经颅超声刺激与脑电记录同步的系统
KR20200049241A (ko) * 2018-10-31 2020-05-08 (주)클래시스 뇌질환 치료를 위한 초음파 장치
CN111888671A (zh) 2020-08-06 2020-11-06 上海交通大学 一种用于人体经颅超声刺激的超声换能器耦合装置

Also Published As

Publication number Publication date
NL2035948B1 (en) 2025-04-11

Similar Documents

Publication Publication Date Title
US11013938B2 (en) Methods and systems for peripheral nerve modulation using non ablative focused ultrasound with electromyography (EMG) monitoring
US10413757B2 (en) Systems and devices for coupling ultrasound energy to a body
KR102124422B1 (ko) 고강도-저강도 집속초음파 치료장치
King et al. Effective parameters for ultrasound-induced in vivo neurostimulation
Gavrilov et al. A study of reception with the use of focused ultrasound. I. Effects on the skin and deep receptor structures in man
US20250303198A1 (en) Systems and Methods Using Ultrasound for Treatment
US20160038770A1 (en) Focused transcranial ultrasound systems and methods for using them
WO2017113179A1 (fr) Dispositif et système de casque de stimulation ultrasonore
US11058900B2 (en) Methods and apparatus for treating a cervix with ultrasound energy
KR20160010831A (ko) 통증 조절 및 근육 강화를 위한 저강도 집속 초음파 자극 장치
CN105536156A (zh) 一种基于大规模面阵元的超声脑刺激或调控方法及装置
US11020617B2 (en) Methods and systems for peripheral nerve modulation using non ablative focused ultrasound with electromyography (EMG) monitoring
Jun Ultrasound as a noninvasive neuromodulation tool
CA2723791C (fr) Procede et systeme permettant un profil combine de therapie energetique
CN104857641A (zh) 一种便携式经颅超声脑调控仪
Gavrilov Focused ultrasound stimulation of the peripheral nervous system: physical basis and practical applications
US20200147415A1 (en) Methods and systems for selective modulation of motor neuronal activity in the peripheral nervous system
WO2025075501A1 (fr) Dispositif de stimulation ultrasonore transcrânienne
Jo et al. Ultrasound brain stimulation technologies for targeted therapeutics
Gavrilov Use of focused ultrasound for stimulation of various neural structures
CN117205457A (zh) 一种体外聚焦超声治疗装置
Machado et al. Low intensity focused ultrasound modulation of neural circuits activity
CA3016001C (fr) Dispositif de traitement implantable generant des ultrasons pour le traitement de la moelle epiniere et/ou du nerf rachidien, appareil comprenant un tel dispositif et procede
Zeng MONITORING AND EXPLORING THE BIO-EFFECTS OF ULTRASOUND NEUROMODULATION ON THE CENTRAL NERVOUS SYSTEM
Lai et al. Medical ultrasound application beyond imaging: insights from ultrasound sensing and biological response

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24786902

Country of ref document: EP

Kind code of ref document: A1